Brown Advisory’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.78M | Buy |
7,134
+1,104
| +18% | +$467K | ﹤0.01% | 662 |
|
|
2026
Q1 | $2.85M | Sell |
6,030
-9,857
| -62% | -$4.96M | ﹤0.01% | 618 |
|
|
2025
Q4 | $7.42M | Buy |
15,887
+9,967
| +168% | +$4.63M | 0.01% | 466 |
|
|
2025
Q3 | $2.52M | Buy |
5,920
+1,672
| +39% | +$648K | ﹤0.01% | 623 |
|
|
2025
Q2 | $1.63M | Sell |
4,248
-382
| -8% | -$138K | ﹤0.01% | 697 |
|
|
2025
Q1 | $1.6M | Buy |
4,630
+1,622
| +54% | +$522K | ﹤0.01% | 671 |
|
|
2024
Q4 | $903K | Sell |
3,008
-586
| -16% | -$205K | ﹤0.01% | 831 |
|
|
2024
Q3 | $1.46M | Buy |
3,594
+1,611
| +81% | +$590K | ﹤0.01% | 705 |
|
|
2024
Q2 | $637K | Sell |
1,983
-129
| -6% | -$41.9K | ﹤0.01% | 883 |
|
|
2024
Q1 | $704K | Buy |
2,112
+200
| +10% | +$61.1K | ﹤0.01% | 864 |
|
|
2023
Q4 | $518K | Sell |
1,912
-254
| -12% | -$62.8K | ﹤0.01% | 927 |
|
|
2023
Q3 | $533K | Buy |
2,166
+11
| +0.5% | +$3.01K | ﹤0.01% | 889 |
|
|
2023
Q2 | $654K | Sell |
2,155
-62
| -3% | -$17.2K | ﹤0.01% | 843 |
|
|
2023
Q1 | $585K | Buy |
2,217
+149
| +7% | +$37.8K | ﹤0.01% | 880 |
|
|
2022
Q4 | $496K | Buy |
2,068
+593
| +40% | +$133K | ﹤0.01% | 909 |
|
|
2022
Q3 | $271K | Buy |
1,475
+279
| +23% | +$55.6K | ﹤0.01% | 995 |
|
|
2022
Q2 | $201K | Hold |
1,196
| – | – | ﹤0.01% | 1046 |
|
|
2022
Q1 | $299K | Buy |
+1,196
| New | +$300K | ﹤0.01% | 968 |
|
|
2021
Q3 | – | Sell |
-1,429
| Closed | -$295K | – | 1126 |
|
|
2021
Q2 | $295K | Buy |
1,429
+109
| +8% | +$22.2K | ﹤0.01% | 947 |
|
|
2021
Q1 | $249K | Sell |
1,320
-314
| -19% | -$55.4K | ﹤0.01% | 987 |
|
|
2020
Q4 | $269K | Buy |
+1,634
| New | +$239K | ﹤0.01% | 895 |
|
|
2020
Q2 | – | Sell |
-2,334
| Closed | -$210K | – | 971 |
|
|
2020
Q1 | $210K | Sell |
2,334
-180
| -7% | -$23.3K | ﹤0.01% | 856 |
|
|
2019
Q4 | $372K | Buy |
+2,514
| New | +$338K | ﹤0.01% | 830 |
|
|
2019
Q2 | – | Sell |
-2,605
| Closed | -$340K | – | 1130 |
|
|
2019
Q1 | $340K | Sell |
2,605
-1,117
| -30% | -$150K | ﹤0.01% | 1090 |
|
|
2018
Q4 | $463K | Buy |
3,722
+447
| +14% | +$60K | ﹤0.01% | 949 |
|
|
2018
Q3 | $455K | Buy |
3,275
+409
| +14% | +$50.9K | ﹤0.01% | 1026 |
|
|
2018
Q2 | $294K | Sell |
2,866
-109
| -4% | -$11K | ﹤0.01% | 1113 |
|
|
2018
Q1 | $288K | Sell |
2,975
-564
| -16% | -$54.7K | ﹤0.01% | 983 |
|
|
2017
Q4 | $311K | Buy |
+3,539
| New | +$284K | ﹤0.01% | 1035 |
|
Other funds holding HCA
Brown Advisory's HCA Position: Q2 2026 in Review
Brown Advisory increased its HCA Healthcare (HCA) stake by 18% in Q2 2026, buying an estimated $467K and bringing the position to 7,134 shares worth $2.78M. The position accounts for ﹤0.01% of the portfolio, ranked #662.
Brown Advisory first reported a position in HCA in Q4 2017 and has held it in 29 quarters since. The position peaked at $7.42M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Brown Advisory held 7,134 shares of HCA Healthcare worth $2.78M as of Q2 2026.
- Brown Advisory bought 1,104 HCA Healthcare shares in Q2 2026, an estimated $467K.
- HCA Healthcare made up ﹤0.01% of Brown Advisory's portfolio in Q2 2026, its #662 holding.
- Brown Advisory first reported a position in HCA Healthcare in Q4 2017 and has held it in 29 quarters since.
- Brown Advisory's HCA Healthcare position peaked at $7.42M in Q4 2025.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.